Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.93
+0.03 (0.22%)
Aug 14, 2025, 1:45 PM - Market open

Crescent Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024
Period Ending
Aug '25 Dec '24
Debt / Equity Ratio
-3.26-3.26
Quick Ratio
3.623.62
Current Ratio
3.623.62
Updated Jun 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q